The SUMO-activating enzyme subunit 1⁄2 (SAE1/SAE2) may promote metastasis in MYC-driven breast cancer [110], and the SUMO-conjugating E2 enzyme UBC9 has also been shown to advance metastasis in breast cancer [111]. Here, UBE2I is linked to breast carcinoma.